Finasteride Tablet, Film Coated
Product Images NDC 71205-767

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 71205-767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Finasteride Figure 1 (Finasteride Fig.1.jpg)

A line graph comparing the mean change from baseline with standard error over four years for Finasteride 5 mg and placebo groups. The y-axis shows mean change with values from 0 to -6, and the x-axis shows time points from baseline to year 4. Two lines represent Finasteride and placebo, with sample sizes indicated at each time point below the x-axis.*

FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2.jpg)

A line chart comparing the cumulative percent of patients over 48 months between Finasteride and placebo groups. The y-axis shows percent of patients (0% to 15%), and the x-axis shows observation time in months (0 to 48). Below the chart, tables list the cumulative number of events and yearly patient counts for both groups throughout the study period.*

FDA Label Image

Finasteride Figure 2 (Finasteride Fig.3.jpg)

Line graph showing the mean percent change from baseline plus one standard error over four years for two groups: placebo and finasteride. The x-axis is labeled by baseline and years 1 through 4. The y-axis measures mean percent change from -20 to 20. Finasteride group shows a decline below baseline over time, while placebo group shows an increase above baseline. Sample sizes for each group per time point are listed below the x-axis.*

FDA Label Image

Finasteride Figure 4 (Finasteride Fig.4.jpg)

A line graph showing the percent of participants with an event over years from randomization, comparing four groups: Placebo, Finasteride, Doxazosin, and Combination. The x-axis represents years from 0 to 5.5, and the y-axis shows percent with event from 0 to 25. Each treatment group is depicted with distinct markers and corresponding event rates over time.*

FDA Label Image

Structutre (Finasteride Structure)

Chemical structure of finasteride showing its molecular arrangement with labeled chemical groups including a ketone and a tert-butyl amide group.*

FDA Label Image

Finasteride-fig.3_ (Fig 3finasteride)

A clinical study graph showing the cumulative percentage of patients over 48 months comparing Finasteride and placebo groups. The Y-axis represents the percent of patients, and the X-axis is the observation time in months. The graph includes cumulative events and risk numbers for both groups listed beneath.*

FDA Label Image

71205-767-30 (Finasteride 5mg 30tab)

Label for Finasteride 5 mg film-coated tablets by Proficient Rx LP. The label indicates 30 tablets per package with each tablet containing 5 mg of Finasteride, USP. Tablets are described as blue, 7 mm round, biconvex, film-coated, marked "F5" on one side. Manufacturer listed as Alkem Laboratories Ltd., India. The label includes storage instructions, warnings against use by women or children, and caution about handling crushed or broken tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.